Invisible enemies: Revolutionizing infection control and microbial identification
Abstract
Detect invisible enemies with speed and precision to enhance infection control in your healthcare institution.
Infection control prevents or stops the spread of infections in healthcare settings. The Bruker IR Biotyper, using Fourier Transform Infrared (FT-IR) spectroscopy, can differentiate microorganisms on the strain level, supporting infection control practices and timely data results.
Join Dr. Philip Jessmon as he demonstrates the value of the IR Biotyper technology along with the complementary MALDI Biotyper technology for rapid microorganism identification.
Key learning objectives:
- Summarize the impact on hospital hygiene for receiving rapid microbial results
- Identify how Fourier Transform-Infrared (FT-IR) spectroscopy technology is used for outbreak identification
- Assess how an FT-IR solution impacts infection control and prevention
Who should attend?
- Clinical microbiologists
- Lab directors, managers, supervisors and technicians
- Hospital administrators
- Epidemiologists
- Infection prevention specialists
- Infection control nurses
- Infection preventionists
- Infectious disease doctors
- Research or clinical PhDs
- Certified infection control (CIC) credentialed people
- Public health laboratory technicians
- Directors/Managers/Supervisors
- AMR stewardship committee members
Speaker
Dr. Philip Jessmon
Product Specialist, Bruker
Dr. Jessmon is a Biotechnology Business & Technical Specialist with extensive experience in microbial testing, molecular solutions, genetic technologies, and cell biology. He has a PhD in Anatomy & Cellular Biology. He has grown a career in the Microbiology space, working for many years as an Applications Specialist, an Account Executive, and now as a Product Specialist supporting the Americas. He loves to educate and support the development of scientific projects at partner laboratories. In particular, he is focused on publishing, webinars, podcasts, and other avenues of sharing project success using the IR Biotyper within our global scientific community.
